Physician

Ali Amin Khan, M.D.

According to 2025 Medicare claims, Ali Khan, M.D. (NPI: 1326278417) practices pulmonary disease in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60026-1301. Khan is affiliated with the Mercy Health Corporation (ACO ID: A2097), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 502 traditional Medicare patients, billed 1,179 HCPCS/CPT codes, and received $85,148 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 825 prescription claims across 215 beneficiaries totaling $1,770,539 in drug costs, led by Tyvaso Dpi (Treprostinil). DME data shows 234 claims. Open Payments data shows 7 records totaling $539. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,800 and ending at $85,148. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $62,175 and ending at $1,770,539. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $17,687 and ending at $22,291.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	21	24	$3,800
2017	124	295	$31,026
2018	361	1,192	$125,463
2019	364	998	$97,468
2020	367	982	$110,187
2021	326	881	$101,266
2022	319	896	$104,370
2023	229	499	$54,803
2024	502	1,179	$85,148

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	23	55	$62,175
2018	67	652	$2,760,268
2019	95	956	$2,508,442
2020	82	895	$1,912,468
2021	79	880	$1,916,052
2022	86	941	$3,046,675
2023	97	849	$3,707,392
2024	215	825	$1,770,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	13	217	$183,049
2019	19	549	$659,217
2020	15	631	$744,866
2021	12	491	$720,011
2022	N/R	377	$574,860
2023	N/R	443	$604,282
2024	N/R	234	$208,583

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	70	120	$175
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	104	104	$97
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	91	164	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	122	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	86	101	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tyvaso Dpi	Treprostinil	30	840	$707,439
Uptravi	Selexipag	13	342	$413,010
Opsumit	Macitentan	19	570	$241,331
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	2,790	$59,248
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	870	$13,616

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J3285	Injection, treprostinil, 1 mg	N	N/R	41	$187,566
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	24	$9,506
K0455	Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)	Y	N/R	22	$6,226
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$2,354
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	40	$1,683

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$539	United Therapeutics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Amin Khan, M.D.?

Tedicare shows public-source Medicare data for Ali Amin Khan, M.D. (NPI 1326278417), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Amin Khan, M.D. have ACO affiliation data?

Ali Amin Khan, M.D. is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097).

What billing organization is linked to Ali Amin Khan, M.D.?

Ali Amin Khan, M.D. is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Ali Amin Khan, M.D. have Open Payments data?

Ali Amin Khan, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.